Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Valvular Heart Disease

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 39 articles: HTML format Text format

Single Articles

July 2019
1. ADAMO M, Grasso C, Capodanno D, Rubbio AP, et al
   Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry.
   Am Heart J. 2019;217:32-41.
   PubMed     Text format     Abstract available
   
   
   April 2019
2. LARIOS G, Yim D, Dragulescu A, Mertens L, et al
   Right ventricular function in patients with pulmonary regurgitation with versus without tetralogy of Fallot.
   Am Heart J. 2019;213:8-17.
   PubMed     Text format     Abstract available
   
   
   March 2019
3. BING R, Everett RJ, Tuck C, Semple S, et al
   Rationale and design of the randomized, controlled Early Valve Replacement Guided by Biomarkers of Left Ventricular Decompensation in Asymptomatic Patients with Severe Aortic Stenosis (EVOLVED) trial.
   Am Heart J. 2019;212:91-100.
   PubMed     Text format     Abstract available
   
   
   August 2018
4. VAN MIEGHEM NM, Unverdorben M, Valgimigli M, Mehran R, et al
   EdoxabaN Versus standard of care and theIr effectS on clinical outcomes in pAtients havinG undergonE Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial.
   Am Heart J. 2018;205:63-69.
   PubMed     Text format     Abstract available
   
   
   
5. MACK MJ, Abraham WT, Lindenfeld J, Bolling SF, et al
   Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
   Am Heart J. 2018;205:1-11.
   PubMed     Text format     Abstract available
   
   
   July 2018
6. FEYZ L, El Faquir N, Lemmert ME, Misier KR, et al
   Prevalence and consequences of noncardiac incidental findings on preprocedural imaging in the workup for transcatheter aortic valve implantation, renal sympathetic denervation, or MitraClip implantation.
   Am Heart J. 2018;204:83-91.
   PubMed     Text format     Abstract available
   
   
   June 2018
7. COLLET JP, Berti S, Cequier A, Van Belle E, et al
   Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial.
   Am Heart J. 2018;200:44-50.
   PubMed     Text format     Abstract available
   
   
   
8. STEINVIL A, Buchanan KD, Kiramijyan S, Bond E, et al
   Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement.
   Am Heart J. 2018;200:11-16.
   PubMed     Text format     Abstract available
   
   
   May 2018
9. SAMAD Z, Shaw LK, Phelan M, Glower DD, et al
   Long-term outcomes of mitral regurgitation by type and severity.
   Am Heart J. 2018;203:39-48.
   PubMed     Text format     Abstract available
   
   
   
10. SHIBATA K, Yamamoto M, Kano S, Koyama Y, et al
    Importance of Geriatric Nutritional Risk Index assessment in patients undergoing transcatheter aortic valve replacement.
    Am Heart J. 2018;202:68-75.
    PubMed     Text format     Abstract available
    
    
    
11. CZARNECKI A, Qiu F, Koh M, Alter DA, et al
    Trends in the incidence and outcomes of patients with aortic stenosis hospitalization.
    Am Heart J. 2018;199:144-149.
    PubMed     Text format     Abstract available
    
    
    April 2018
12. EL-HARASIS MA, Connolly HM, Miranda WR, Qureshi MY, et al
    Progressive right ventricular enlargement due to pulmonary regurgitation: Clinical characteristics of a "low-risk" group.
    Am Heart J. 2018;201:136-140.
    PubMed     Text format     Abstract available
    
    
    
13. GALPER BZ, Beery DE, Leighton G, Englander LL, et al
    Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and Mitraclip procedures as reported by the Transcatheter Valve Therapy Registry and the Food and Drug Administration postmarket surveillance data.
    Am Heart J. 2018;198:64-74.
    PubMed     Text format     Abstract available
    
    
    March 2018
14. FANNING JP, Wesley AJ, Walters DL, Wong AA, et al
    Topographical distribution of perioperative cerebral infarction associated with transcatheter aortic valve implantation.
    Am Heart J. 2018;197:113-123.
    PubMed     Text format     Abstract available
    
    
    February 2018
15. BUCHANAN KD, Rogers T, Alraies MC, Steinvil A, et al
    Temporal trends in patient referral for Transcatheter aortic valve replacement and reasons for exclusion at a high-volume Center in the United States.
    Am Heart J. 2018;196:74-81.
    PubMed     Text format     Abstract available
    
    
    
16. EGBE A, Khan AR, Miranda WR, Ammash NM, et al
    Mechanism for temporal changes in exercise capacity after Fontan palliation: Role of Doppler echocardiography.
    Am Heart J. 2018;196:144-152.
    PubMed     Text format     Abstract available
    
    
    January 2018
17. VEMULAPALLI S, Holmes DR Jr, Dai D, Matsouaka R, et al
    Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry.
    Am Heart J. 2018;195:1-13.
    PubMed     Text format     Abstract available
    
    
    
18. BANOVIC M, Iung B, Bartunek J, Penicka M, et al
    The Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A protocol update.
    Am Heart J. 2018;195:153-154.
    PubMed     Text format    
    
    
    December 2017
19. BARON SJ, Arnold SV, Reynolds MR, Wang K, et al
    Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial.
    Am Heart J. 2017;194:39-48.
    PubMed     Text format     Abstract available
    
    
    
20. LEE S, Kang DH, Kim DH, Song JM, et al
    Late outcome of percutaneous mitral commissurotomy: Randomized comparison of Inoue versus double-balloon technique.
    Am Heart J. 2017;194:1-8.
    PubMed     Text format     Abstract available
    
    
    October 2017
21. MOJOLI M, Gersh BJ, Barioli A, Masiero G, et al
    Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Am Heart J. 2017;192:64-75.
    PubMed     Text format     Abstract available
    
    
    
22. KESSLER M, Gonska B, Seeger J, Rottbauer W, et al
    Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve.
    Am Heart J. 2017;192:57-63.
    PubMed     Text format     Abstract available
    
    
    July 2017
23. VEMULAPALLI S, Lippmann SJ, Krucoff M, Hernandez AF, et al
    Cardiovascular events and hospital resource utilization pre- and post-transcatheter mitral valve repair in high-surgical risk patients.
    Am Heart J. 2017;189:146-157.
    PubMed     Text format     Abstract available
    
    
    
24. ROGERS T, Torguson R, Bastian R, Corso P, et al
    Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study.
    Am Heart J. 2017;189:103-109.
    PubMed     Text format     Abstract available
    
    
    June 2017
25. GOLDBERG SL, Meredith I, Marwick T, Haluska BA, et al
    A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR study.
    Am Heart J. 2017;188:167-174.
    PubMed     Text format     Abstract available
    
    
    May 2017
26. ARENDT CJ, Hong JH, Daly RC, Scott C, et al
    Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery.
    Am Heart J. 2017;187:70-77.
    PubMed     Text format     Abstract available
    
    
    
27. HO CY, McMurray JJV, Cirino AL, Colan SD, et al
    The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.
    Am Heart J. 2017;187:145-155.
    PubMed     Text format     Abstract available
    
    
    March 2017
28. KLECZYNSKI P, Dziewierz A, Bagienski M, Rzeszutko L, et al
    Impact of frailty on mortality after transcatheter aortic valve implantation.
    Am Heart J. 2017;185:52-58.
    PubMed     Text format     Abstract available
    
    
    February 2017
29. MARTIN GP, Sperrin M, Ludman PF, de Belder MA, et al
    Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation.
    Am Heart J. 2017;184:97-105.
    PubMed     Text format     Abstract available
    
    
    
30. KOIFMAN E, Didier R, Patel N, Jerusalem Z, et al
    Impact of right ventricular function on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement.
    Am Heart J. 2017;184:141-147.
    PubMed     Text format     Abstract available
    
    
    
31. SORENSEN LL, Liang HY, Pinheiro A, Hilser A, et al
    Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
    Am Heart J. 2017;184:47-54.
    PubMed     Text format     Abstract available
    
    
    December 2016
32. SPITZER E, Van Mieghem NM, Pibarot P, Hahn RT, et al
    Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial.
    Am Heart J. 2016;182:80-88.
    PubMed     Text format     Abstract available
    
    
    
33. PRESSLER A, Christle JW, Lechner B, Grabs V, et al
    Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: A randomized pilot trial.
    Am Heart J. 2016;182:44-53.
    PubMed     Text format     Abstract available
    
    
    
34. DAHYA V, Xiao J, Prado CM, Burroughs P, et al
    Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:21-27.
    PubMed     Text format     Abstract available
    
    
    
35. CHAUHAN D, Haik N, Merlo A, Haik BJ, et al
    Quantitative increase in frailty is associated with diminished survival after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:146-154.
    PubMed     Text format     Abstract available
    
    
    October 2016
36. WINDECKER S, Tijssen J, Giustino G, Guimaraes AH, et al
    Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
    Am Heart J. 2016;184:81-87.
    PubMed     Text format     Abstract available
    
    
    
37. VOLLENBROICH R, Stortecky S, Praz F, Lanz J, et al
    The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2016;184:71-80.
    PubMed     Text format     Abstract available
    
    
    September 2016
38. THUNE JJ, Pehrson S, Nielsen JC, Haarbo J, et al
    Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Am Heart J. 2016;179:136-41.
    PubMed     Text format     Abstract available
    
    
    August 2016
39. MARTINS RP, Galand V, Colette E, Behar N, et al
    Defining nonvalvular atrial fibrillation: A quest for clarification.
    Am Heart J. 2016;178:161-7.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: